Verily says that the watch can record and display single-channel ECG rhythms. Along with research trials, doctors can prescribe the device to individuals as part of their clinical care. "Receiving this authorization demonstrates our commitment to the FDA's high standards in terms of safety and effectiveness, and will help us advance the Study Watch application in various disease areas and future directions," Verily said in a blog post.
Study Watch is not a consumer device, but now Verily has obtained approval from the FDA, it is not impossible to imagine that Google borrows the ECG technology for a Pixel Watch or its Wear OS platform. After all, Google has just purchased Fossil's smart watch technology for $ 40 million, which underscores its commitment to wearables. Since Apple is having a huge impact with its own ECG tool in Apple Watch Series 4, it's not unlikely that Google wants to offer more health-focused options within its smart watch ecosystem.